Abstract: A system having a device for producing a pipeline unit from a pipeline having a pipeline outer surface and a pipe connector having a pipe connector outer surface. Also described is a method for producing the system.

Abstract: In the technical field of compressors, a system that is configured to supply a mixture of air and exhaust gas to a compressor wheel of a compressor is provided. The system comprises a main channel that is configured to debouch into an area where the compressor wheel is located at an outlet end thereof, to receive a supply of air in a first section thereof, and to receive a supply of exhaust gas further downstream in a second section thereof, and an exhaust gas supply arrangement that is connected to the main channel at the position of the second section. The exhaust gas supply arrangement is designed as a distributor comprising at least two exhaust gas supply channels which are separate from each other along at least a substantial part of their length.

Abstract: The invention relates to a product for the release of highly lipophilic physiologically active substances, comprising a core and a coating on top of the core, the coating comprising one or more highly lipophilic physiologically active substances, one or more water-soluble film-forming agents and, relative to the weight of all components, not more than 20 wt % of other auxiliary substances.

Abstract: The invention relates to a solid dosage form that comprises a matrix with one or more highly lipophilic physiologically active substances, one or more water-soluble binders and, relative to the weight of all components, not more than 20 wt % of other auxiliary substances, wherein a physiologically active substance being highly lipophilic if it has a log P of 4 or more.

Abstract: Pharmaceutical formulation in the form of a solid dispersion, wherein the solid dispersion comprises in admixture a cannabinoid, an amphiphilic block copolymer as a solubilizer and a water-soluble film former. A method for preparing a formulation as defined, wherein the method comprises the following steps: (i) preparing a liquid composition comprising the cannabinoid, the amphiphilic block copolymer and a solvent capable of at least partially dissolving the cannabinoid and the amphiphilic block copolymer; (ii) introducing the liquid composition into a fluid bed granulator; (iii) removing solvent to obtain a solid dispersion in particulate form; and (iv) recovering the solid dispersion in particulate form from the fluid bed granulator.

Abstract: Uses and formulations of cannabinoids, in particular of cannabidiol, are provided. The cannabinoids, in particular cannabidiol, are used for the treatment of patients suffering from inflammatory conditions associated with autoimmune diseases, chronic inflammatory diseases and inflammatory conditions in connection with infections, including cytokine release syndrome (CRS). Formulations are especially for oral administration of cannabinoids, in particular of cannabidiol. These formulations are useful for treating patients suffering from conditions as referred to above.

Abstract: Uses and formulations of cannabinoids, in particular of cannabidiol, are provided. The cannabinoids, in particular cannabidiol, are used for the treatment of patients suffering from COVID-19, a disease caused by the coronavirus SARS-Cov-2. Formulations are especially for oral administration of cannabinoids, in particular of cannabidiol. These formulations are useful for treating patients suffering from COVID-19.

Abstract: Uses and formulations of cannabinoids, in particular of cannabidiol, are provided. The cannabinoids, in particular cannabidiol, are used for the treatment of patients suffering from COVID-19, a disease caused by the coronavirus SARS-Cov-2. Formulations are especially for oral administration of cannabinoids, in particular of cannabidiol. These formulations are useful for treating patients suffering from COVID-19.

Abstract: Uses and formulations of cannabinoids, in particular of cannabidiol, are provided. The cannabinoids, in particular cannabidiol, are used for the treatment of patients suffering from inflammatory conditions associated with autoimmune diseases, chronic inflammatory diseases and inflammatory conditions in connection with infections, including cytokine release syndrome (CRS). Formulations are especially for oral administration of cannabinoids, in particular of cannabidiol. These formulations are useful for treating patients suffering from conditions as referred to above.

Abstract: A filling device for dosing a defined amount of loose-type material with a filling unit including a basic body and a control device.

Abstract: A process and to an apparatus for production of a granular cannabinoid material essentially soluble in aqueous medium, wherein a matrix liquid composed of a first liquid that dissolves a cannabinoid or composed of a first liquid that dissolves a cannabinoid and a second liquid that forms an emulsion with the first liquid and a cannabinoid dissolved in the first liquid or emulsion is produced. The matrix liquid is dried by convection, and wherein the apparatus has a vessel system having an inlet and a matrix liquid outlet for production of the matrix liquid and a drying apparatus fluidically connected to the matrix liquid outlet of the vessel system.

Abstract: An archiving system for archiving electronic data in memory of the archiving system in an audit-proof manner and a related method for archiving electronic data on the archiving system.

Abstract: The invention relates to an arrangement for installing cables on outer surfaces of crane structures (1), the arrangement comprising means (9) for routing and fastening cables to said surfaces. These means consist of T profiles (9) fastened at the stem part (10) of the T profile to the outer surface (1) of the crane structure, the upper part (11) of the T profile on top of and transverse to the stem part of the T profile being at a distance from the surface of the crane and substantially parallel to this surface, whereby the T profile together with the surface of the crane provide cable conduits (12) for the cables, which are open from the sides.

Abstract: The invention relates to an arrangement for installing cables on outer surfaces of crane structures (1), the arrangement comprising means (9) for routing and fastening cables to said surfaces. These means consist of T profiles (9) fastened at the stem part (10) of the T profile to the outer surface (1) of the crane structure, the upper part (11) of the T profile on top of and transverse to the stem part of the T profile being at a distance from the surface of the crane and substantially parallel to this surface, whereby the T profile together with the surface of the crane provide cable conduits (12) for the cables, which are open from the sides.